(Q44574421)

4 December 2017

title

Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans (English)

1 reference

4 December 2017

0 references

Mehmet Sofuoglu

1

1 reference

4 December 2017

Amrita Singha

2

1 reference

4 December 2017

Thomas R Kosten

3

1 reference

4 December 2017

F Elinore McCance-Katz

4

1 reference

4 December 2017

Ismene Petrakis

5

1 reference

4 December 2017

Alison Oliveto

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Pharmacology, Biochemistry and Behavior

4 December 2017

published in

1 reference

4 December 2017

volume

75

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

801-808

1 reference

Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Opioidergic modulation of cocaine conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Opiate antagonists reduce cocaine but not nicotine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Utility of subjective-effects measurements in assessing abuse liability of drugs in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Naltrexone treatment of comorbid alcohol and cocaine use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Cocaine plasma concentration: relation to physiological and subjective effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Isradipine prevents global and regional cocaine-induced changes in brain blood flow: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Intravenous cocaine challenges during naltrexone maintenance: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Interactions of cocaine with nimodipine: a brief report.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2+ channel modulators.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

The effects of naltrexone on alcohol and cocaine use in dually addicted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Calcium receptor antagonists modify cocaine effects in the central nervous system differently.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Cocaine-calcium channel antagonist interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Pharmacological mechanisms in cocaine's cardiovascular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

Naltrexone and relapse prevention treatment for cocaine-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900157-6

7 January 2021

10.1016/S0091-3057(03)00157-6

Identifiers

DOI

1 reference

4 December 2017

1 reference